title: [Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].
abstract: OBJECTIVE
  To report on the results of pars plana vitrectomy and intravitreal triamcinolone in patients with chronic pseudophakic cystoid macular edema unresponsive to medical treatment.
  
  
  METHODS
  A retrospective analysis of 9 eyes in 9 patients with chronic pseudophakic cystoid macular edema was performed. All patients had cystoid macular edema confirmed on fluorescein angiography, and were unresponsive to medical treatment. In all patients pars plana vitrectomy and intravitreal application of 4 mg of triamcinolone was performed. In one patient with vitreous prolapse into the anterior chamber, anterior vitrectomy was also required.
  
  
  RESULTS
  The mean interval between cataract surgery and vitrectomy was 16.28 +/- 2.1 months. The mean preoperative best corrected visual acuity was 0.1 +/- 0.11, and the mean final best corrected visual acuity 0.25 +/- 0.24, after a mean follow up of 6.6 +/- 3.5 months. In all 9 eyes there was a marked reduction of cystoid macular edema, as verified on fluorescein angiography. Intraocular pressure was raised in 4 patients, and it was controlled by topical antiglaucomatous treatment.
  
  
  CONCLUSIONS
  Pars plana vitrectomy and intravitreal triamcinolone in eyes with chronic pseudophakic cystoid macular edema resulted in a reduction of cystoid macular edema, and visual acuity improvement.
authors.affiliation: Klinika za ocne bolesti, Klinicka bolnica Sestre milosrdniceo, Zagreb, Hrvatska.
authors.forename: Goran
authors.initials: G
authors.lastname: Bencić
authors.forename: Zoran
authors.initials: Z
authors.lastname: Vatavuk
authors.forename: Zdravko
authors.initials: Z
authors.lastname: Mandić
mesh_terms: D000368:Aged; D002387:Cataract Extraction; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007429:Intraocular Pressure; D008269:Macular Edema / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019591:Pseudophakia / Q000150:complications; D014221:Triamcinolone / Q000008:administration & dosage*; D014792:Visual Acuity; D014821:Vitrectomy; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014221:Triamcinolone